Literature DB >> 25769212

Feasibility of catheter-directed intraluminal irreversible electroporation of porcine ureter and acute outcomes in response to increasing energy delivery.

Govindarajan Srimathveeravalli1, Mikhail Silk2, Thomas Wimmer3, Sebastien Monette4, Simon Kimm5, Majid Maybody2, Stephen B Solomon2, Jonathan Coleman5, Jeremy C Durack2.   

Abstract

PURPOSE: To evaluate the feasibility of focal intraluminal irreversible electroporation (IRE) in the ureter with a novel electrode catheter and to study the treatment effects in response to increasing pulse strength.
MATERIALS AND METHODS: Five IRE treatment settings were each evaluated twice for the ablation of normal ureter in 5 Yorkshire pigs (n = 1-4 ablations per animal; total of 10 ablations) with the use of a prototype device under ultrasound and fluoroscopic guidance. Animals received unilateral or bilateral treatment, limited to a maximum of 2 ablations in any 1 ureter. Treatment was delivered with increasing pulse strength (from 1,000 V to 3,000 V in increments of 500 V) while keeping the pulse duration (100 μs) and number of pulses (n = 90) constant. Ureter patency was assessed with antegrade ureteropyelography immediately following treatment. Animals were euthanized within 4 hours after treatment, and treated urinary tract was harvested for histopathologic analysis with hematoxylin and eosin and Masson trichrome stains.
RESULTS: IRE was successfully performed in all animals, without evidence of ureteral perforation. Hematoxylin and eosin analysis of IRE treatments demonstrated full-thickness ablation at higher field strengths (mucosa to the adventitia). Masson trichrome stains showed preservation of connective tissue at all field strengths.
CONCLUSIONS: Intraluminal catheter-directed IRE ablation is feasible and produces full-thickness ablation of normal ureters. There was no evidence of lumen perforation even at the maximum voltages evaluated.
Copyright © 2015 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25769212      PMCID: PMC4478125          DOI: 10.1016/j.jvir.2015.01.020

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  20 in total

1.  Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.

Authors:  Robert C G Martin; Kelli McFarland; Susan Ellis; Vic Velanovich
Journal:  J Am Coll Surg       Date:  2012-06-21       Impact factor: 6.113

2.  Irreversible electroporation of the liver and liver hilum in swine.

Authors:  Kevin P Charpentier; Farrah Wolf; Lelia Noble; Brody Winn; Murray Resnick; Damian E Dupuy
Journal:  HPB (Oxford)       Date:  2011-01-25       Impact factor: 3.647

3.  Some observations on the regeneration of smooth muscle in the repaired urinary bladder of the rabbit.

Authors:  S D Gorham; D A French; A A Shivas; R Scott
Journal:  Eur Urol       Date:  1989       Impact factor: 20.096

4.  Irreversible electroporation: evaluation of nonthermal and thermal ablative capabilities in the porcine kidney.

Authors:  Ephrem O Olweny; Payal Kapur; Yung K Tan; Samuel K Park; Mehrad Adibi; Jeffrey A Cadeddu
Journal:  Urology       Date:  2013-01-03       Impact factor: 2.649

5.  Renal tissue ablation with irreversible electroporation: preliminary results in a porcine model.

Authors:  Ajita Deodhar; Sébastien Monette; Gordon W Single; William C Hamilton; Raymond Thornton; Majid Maybody; Jonathan A Coleman; Stephen B Solomon
Journal:  Urology       Date:  2010-12-15       Impact factor: 2.649

6.  Advanced hepatic ablation technique for creating complete cell death: irreversible electroporation.

Authors:  Edward W Lee; Christine Chen; Veronica E Prieto; Sarah M Dry; Christopher T Loh; Stephen T Kee
Journal:  Radiology       Date:  2010-05       Impact factor: 11.105

Review 7.  Laser therapy for upper urinary tract transitional cell carcinoma: indications and management.

Authors:  Markus J Bader; Ronald Sroka; Christian Gratzke; Michael Seitz; Patrick Weidlich; Michael Staehler; Armin Becker; Christian G Stief; Oliver Reich
Journal:  Eur Urol       Date:  2008-12-17       Impact factor: 20.096

8.  Percutaneous ablation of peribiliary tumors with irreversible electroporation.

Authors:  Mikhail T Silk; Thomas Wimmer; Kyungmouk S Lee; Govindarajan Srimathveeravalli; Karren T Brown; Peter T Kingham; Yuman Fong; Jeremy C Durack; Constantinos T Sofocleous; Stephen B Solomon
Journal:  J Vasc Interv Radiol       Date:  2013-11-18       Impact factor: 3.464

9.  Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.

Authors:  Govindarajan Narayanan; Peter J Hosein; Geetika Arora; Katuzka J Barbery; Tatiana Froud; Alan S Livingstone; Dido Franceschi; Caio M Rocha Lima; Jose Yrizarry
Journal:  J Vasc Interv Radiol       Date:  2012-12       Impact factor: 3.464

10.  Planning irreversible electroporation in the porcine kidney: are numerical simulations reliable for predicting empiric ablation outcomes?

Authors:  Thomas Wimmer; Govindarajan Srimathveeravalli; Narendra Gutta; Paula C Ezell; Sebastien Monette; Majid Maybody; Joseph P Erinjery; Jeremy C Durack; Jonathan A Coleman; Stephen B Solomon
Journal:  Cardiovasc Intervent Radiol       Date:  2014-05-17       Impact factor: 2.740

View more
  10 in total

1.  Transmural ablation of the normal porcine common bile duct with catheter-directed irreversible electroporation is feasible and does not affect duct patency.

Authors:  Eisuke Ueshima; Mark Schattner; Robin Mendelsohn; Hans Gerdes; Sebastien Monette; Haruyuki Takaki; Jeremy C Durack; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Gastrointest Endosc       Date:  2017-05-10       Impact factor: 9.427

2.  Normal Porcine Ureter Retains Lumen Wall Integrity but Not Patency Following Catheter-Directed Irreversible Electroporation: Imaging and Histologic Assessment over 28 Days.

Authors:  Govindarajan Srimathveeravalli; Francois Cornelis; Thomas Wimmer; Sebastien Monette; Simon Y Kimm; Majid Maybody; Stephen B Solomon; Jonathan A Coleman; Jeremy C Durack
Journal:  J Vasc Interv Radiol       Date:  2017-03-30       Impact factor: 3.464

3.  Catheter-based endobronchial electroporation is feasible for the focal treatment of peribronchial tumors.

Authors:  Hiroshi Kodama; Laurien G Vroomen; Eisuke Ueshima; Jennifer Reilly; Whitney Brandt; Lee-Ronn Paluch; Sebastien Monette; David Jones; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  J Thorac Cardiovasc Surg       Date:  2017-12-20       Impact factor: 5.209

4.  A new intrasurgical technique to safely and reproducibly induce partial unilateral urinary obstruction and renal scarring in a Rat Model.

Authors:  Laurien G P H Vroomen; Nirmal Thampi John; Masashi Fuijmori; Arjun Sivaraman; Diane Felsen; Govindarajan Srimathveeravalli
Journal:  Int Urol Nephrol       Date:  2020-03-02       Impact factor: 2.370

5.  Macrophage-secreted TGF-β1 contributes to fibroblast activation and ureteral stricture after ablation injury.

Authors:  Eisuke Ueshima; Masashi Fujimori; Hiroshi Kodama; Diane Felsen; Jie Chen; Jeremy C Durack; Stephen B Solomon; Jonathan A Coleman; Govindarajan Srimathveeravalli
Journal:  Am J Physiol Renal Physiol       Date:  2019-04-24

6.  Safety and efficacy of magnetic anchoring electrode-assisted irreversible electroporation for gastric tissue ablation.

Authors:  Fenggang Ren; Qingshan Li; Liangshuo Hu; Xiaopeng Yan; Zhongyang Gao; Jing Zhang; Weiman Gao; Zhe Zhang; Pengkang Chang; Xue Chen; Dake Chu; Rongqian Wu; Yi Lv
Journal:  Surg Endosc       Date:  2019-04-22       Impact factor: 4.584

7.  Ablation Zone Involution of Liver Tumors Is Faster in Patients Treated with Irreversible Electroporation Than Microwave Ablation.

Authors:  Fourat Ridouani; Mario Ghosn; Francois Cornelis; Elena N Petre; Meier Hsu; Chaya S Moskowitz; Peter T Kingham; Stephen B Solomon; Govindarajan Srimathveeravalli
Journal:  Medicina (Kaunas)       Date:  2021-08-26       Impact factor: 2.948

Review 8.  Irreversible Electroporation for Prostate Cancer as Salvage Treatment Following Prior Radiation and Cryotherapy.

Authors:  Katie S Murray; Oguz Akin; Jonathan A Coleman
Journal:  Rev Urol       Date:  2017

Review 9.  Ablation of hepatic malignant tumors with irreversible electroporation: A systematic review and meta-analysis of outcomes.

Authors:  Guo Tian; Qiyu Zhao; Fen Chen; Tian'an Jiang; Weilin Wang
Journal:  Oncotarget       Date:  2017-01-24

10.  Feasibility and effectiveness of endoscopic irreversible electroporation for the upper gastrointestinal tract: an experimental animal study.

Authors:  Han Jo Jeon; Hyuk Soon Choi; Bora Keum; Eun Joo Bang; Kang Won Lee; Sang Hyun Kim; Sun Young Yim; Jae Min Lee; Eun Sun Kim; Yeon Seok Seo; Yoon Tae Jeen; Hong Sik Lee; Hoon Jai Chun; Hong Bae Kim; Jong Hyuk Kim
Journal:  Sci Rep       Date:  2021-07-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.